Critical

Acute pulmonary embolism - risk-stratified pathway

PE pathway · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Suspected pulmonary embolism worked up on a risk-stratified pathway: clinical probability (Wells/PERC) guides D-dimer vs imaging, then haemodynamic stratification decides between thrombolysis, monitoring and simple anticoagulation.

Assessment

Investigations

  • Clinical probability (Wells); PERC in low-risk to avoid testing
  • D-dimer if low/intermediate probability; CTPA (or V/Q) to confirm
  • Stratify: high-risk (shock) vs intermediate vs low (e.g. PESI/sPESI); echo/troponin

Management

  • Resuscitate; oxygen; analgesia
  • High-risk (haemodynamic instability): systemic thrombolysis (or embolectomy if contraindicated)
  • Intermediate-risk: anticoagulate and monitor closely for deterioration
  • Low-risk: anticoagulate (DOAC/LMWH); consider ambulatory care (sPESI 0)
  • Anticoagulation choice per renal function/pregnancy/cancer; treat the cause
  • Caution: confirm PE before thrombolysis unless peri-arrest

Drugs & doses

Anticoagulation (DOAC / LMWH)
Systemic thrombolysis (high-risk)
Oxygen / analgesia

Disposition

Per risk; admit or ambulatory.

Stratify PE by haemodynamics - shock means thrombolysis, intermediate-risk means anticoagulate and watch, and low-risk (sPESI 0) may go home on a DOAC.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.